Application Note

Innovating For The Future: Accelerating The Arrival Of Immuno-Oncology 2.0

Gene Therapy GettyImages-852566942

There is a growing interest in a proposed new era of optimized cell therapy manufacturing—referred to as “immuno-oncology 2.0”. This comes alongside growing excitement about the effect of immuno-oncology on modern medicine and several next-generation therapeutics on the horizon. However, before further progress is made, there remain several challenges facing the development of optimized manufacturing processes.

Here we analyze how the innovation of analytical equipment, automation of processes, and scalability of manufacturing are the three key areas where development and collaboration are needed.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene

Thermo Fisher Scientific Bioproduction